Blood Donation After Mononucleosis: Eligibility, Waiting Period, and Guidelines

History of infectious mononucleosis (EBV) is not a permanent deferral for blood donation. Eligibility requires full recovery and meeting standard criteria.

Key Requirements

  • Symptom-Free Interval: FDA/Red Cross: **≥28 days after complete resolution of all symptoms** (fever, fatigue, pharyngitis, lymphadenopathy, splenomegaly).
  • No Active Infection: Must feel well, no fever, no enlarged spleen (splenic rupture risk with exertion/phlebotomy).
  • Standard Eligibility:
    • Age: 17+ (16 with parental consent in some states)
    • Weight: ≥110 lbs (50 kg)
    • Hemoglobin: ≥12.5 g/dL (female), ≥13.0 g/dL (male)
    • No recent high-risk travel, tattoos/piercings (3 mo), certain medications (isotretinoin, finasteride, blood thinners), vaccines (live attenuated: 4 wk deferral).

Why the Wait?

  • EBV establishes lifelong latency in B-cells; viremia resolves but virus persists.
  • Transfusion transmission of EBV is theoretically possible but not documented as causing clinical mono in immunocompetent recipients (most adults are EBV IgG+).
  • Primary concern is donor safety: splenomegaly + phlebotomy/vasovagal → rupture risk.
  • Fatigue/deconditioning may impair post-donation recovery.

Special Considerations

  • Complicated Mono: If hospitalization, splenic rupture, hepatitis, neurologic involvement → longer deferral (3–6 months), physician clearance.
  • Chronic Active EBV: Rare; permanent deferral if persistent viremia/illness.
  • Convalescent Plasma: Different criteria; not standard whole blood donation.

Donation Process Disclosure

At screening, disclose mono history. Staff will ask onset date, symptom duration, resolution date, complications. Honesty ensures safety.

Other Viral Infections

  • CMV, HSV, HIV, HTLV, Hepatitis B/C, West Nile, Zika, Chagas – specific deferrals (some permanent).
  • COVID-19: Symptom-free ≥10 days (or per current FDA guidance).

Always verify with your local blood center (Red Cross, Vitalant, community center) as policies can exceed FDA minimums.

Blood Disorders - Related Articles